AURA BIOSCIENCES INC (AURA) — insider trading
Health Care · NASDAQ
AURA BIOSCIENCES INC (AURA) has 27 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 27 (latest 2026-09-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Kratz Erica | Officer (Chief Reg. & Quality Officer) | Grant / award / vesting (derivative) | 199,115 | — | $0 | Form 4 |
| 2026-09-01 | Kratz Erica | Officer (Chief Reg. & Quality Officer) | Grant / award / vesting | 100,885 | — | $0 | Form 4 |
| 2026-09-01 | Elazzouzi Amy | Officer (SVP, Finance & PAO) | Grant / award / vesting (derivative) | 46,460 | — | $0 | Form 4 |
| 2026-09-01 | Elazzouzi Amy | Officer (SVP, Finance & PAO) | Grant / award / vesting | 23,540 | — | $0 | Form 4 |
| 2026-09-01 | Hopkins Janet Jill | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 116,150 | — | $0 | Form 4 |
| 2026-09-01 | Hopkins Janet Jill | Officer (Chief Medical Officer) | Grant / award / vesting | 58,850 | — | $0 | Form 4 |
| 2026-09-01 | Person Julie | Officer (Chief People Officer) | Grant / award / vesting (derivative) | 212,389 | — | $0 | Form 4 |
| 2026-09-01 | Person Julie | Officer (Chief People Officer) | Grant / award / vesting | 107,611 | — | $0 | Form 4 |
| 2026-09-01 | Abu-Absi Susan | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 265,487 | — | $0 | Form 4 |
| 2026-09-01 | Abu-Absi Susan | Officer (Chief Operating Officer) | Grant / award / vesting | 134,513 | — | $0 | Form 4 |
| 2026-07-07 | Bender Jeremy | Director | Grant / award / vesting (derivative) | 60,000 | — | $0 | Form 4 |
| 2026-07-07 | Bender Jeremy | Director | Grant / award / vesting | 30,000 | — | $0 | Form 4 |
| 2026-07-01 | Kilroy Conor | Officer (See Remarks) | Grant / award / vesting | 14,858 | — | $0 | Form 4 |
| 2026-06-16 | Gibney Anthony S | Officer (See Remarks) | Open-market sale | 12,824 | $6.42 | $82.3K | Form 4 |
| 2026-06-11 | Mattessich Antony C. | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-11 | Mattessich Antony C. | Director | Grant / award / vesting | 15,000 | — | $0 | Form 4 |
| 2026-06-11 | Johnson David Michael | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-11 | Johnson David Michael | Director | Grant / award / vesting | 15,000 | — | $0 | Form 4 |
| 2026-06-11 | Srivastava Sapna | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-11 | Srivastava Sapna | Director | Grant / award / vesting | 15,000 | — | $0 | Form 4 |
| 2026-06-11 | Bitetti Teresa Marie | Director | Grant / award / vesting (derivative) | 30,000 | — | $0 | Form 4 |
| 2026-06-11 | Bitetti Teresa Marie | Director | Grant / award / vesting | 15,000 | — | $0 | Form 4 |
| 2026-05-19 | Holles Natalie C. | Director, Officer (See Remarks) | Grant / award / vesting (derivative) | 2,169,103 | — | $0 | Form 4 |
| 2026-05-19 | Holles Natalie C. | Director, Officer (See Remarks) | Grant / award / vesting | 553,844 | — | $0 | Form 4 |
| 2026-05-19 | Holles Natalie C. | Director, Officer (See Remarks) | Grant / award / vesting | 600,118 | — | $0 | Form 4 |
| 2026-05-07 | Matrix Capital Management Company, LP; GOEL DAVID E. | 10% owner | Open-market sale | 6,922,870 | $5.64 | $39.04M | Form 4 |
| 2026-04-16 | Kilroy Conor | Officer (See Remarks) | Open-market sale | 11,738 | $7.02 | $82.4K | Form 4 |
Ask the chat about AURA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AURA BIOSCIENCES INC (AURA).
Last updated 2026-09-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.